azoximer bromide

10/01/2022 - "tuberculosis), as a classic adjuvant in studies, was used comparatively with the non-toxic polymeric based Polyoxidonium adjuvant. "
01/01/1996 - "CBA mice served as experimental tuberculosis model to study protective, immunomodulating and toxico-allergic properties of two drugs including cytoplasma and cell walls of BCG mycobacteria as well as of synthetic adjuvant polyoxidonium. "
01/01/2010 - "[POLYOXIDONIUM IN COMPLEX PREVENTIVE TREATMENT FOR TUBERCULOSIS IN CHILDREN AND ADOLESCENTS]."
01/01/2010 - "Inclusion of polyoxidonium into the preventive treatment of tuberculosis has shown a higher efficiency of complex preventive therapy and a reduction in the time of using antituberculous drugs for the prevention of tuberculosis, which is very important, bearing in mind fact that there may be adverse reactions when antituberculous treatment is long used."
01/01/2010 - "The paper presents the results of studying the clinical and immunological efficacy of the immunomodulator polyoxidonium in the preventive treatment of tuberculosis in children and adolescents in combination with antituberculous drugs. "

03/01/2006 - "The trial demonstrates that polyoxidonium has a positive action on the disease course, an antiinflammatory, immunomodulating properties, suppresses peroxidation, promotes recovery of structural-functional characteristics of cellular membranes in patients with urolithiasis and secondary pyelonephritis. "
03/01/2006 - "Of 60 patients with secondary pyelonephritis in urolithiasis, 30 received adjuvant polyoxidonium. "
03/01/2006 - "Efficacy of polyoxidonium was studied in combined therapy of urolithiasis complicated with secondary pyelonephritis. "
03/01/2006 - "Polyoxidonium is recommended in secondary pyelonephritis and urolithiasis as adjuvant to basic therapy for anti-inflammatory, detoxication and immunomodulating effect."
11/01/2011 - "The results of the tests show that polyoxidonium has anti-inflammatory and immunomodulating effects, exhibits activity of peroxidation processes, contributes to normalization of a lipid phase of cell membranes and can be recommended as a component of combined treatment of patients with chronic pyelonephritis and urolithiasis."

11/01/2011 - "[Clinicobiochemical and immunological assessment of polyoxidonium efficacy in the treatment of patients with chronic calculous pyelonephritis]."
03/01/2006 - "[Polyoxidonium in the treatment of calculous pyelonephritis]."
03/01/2006 - "The trial demonstrates that polyoxidonium has a positive action on the disease course, an antiinflammatory, immunomodulating properties, suppresses peroxidation, promotes recovery of structural-functional characteristics of cellular membranes in patients with urolithiasis and secondary pyelonephritis. "
03/01/2006 - "Of 60 patients with secondary pyelonephritis in urolithiasis, 30 received adjuvant polyoxidonium. "
03/01/2006 - "Efficacy of polyoxidonium was studied in combined therapy of urolithiasis complicated with secondary pyelonephritis. "

01/01/2011 - "The clinical efficiency of polyoxidonium (Russia) in the treatment of allergic rhinitis has been demonstrated. "
01/01/2011 - "The results of the study confirm the high efficacy of combined therapy of allergic rhinitis with aerius and polyoxidonium."

01/01/2021 - "The immune modulator azoximer bromide (AZB; Polyoxidonium®) is indicated in Russia for use against acute viral infections and during remission. "
01/01/2018 - "Polyoxidonium was well tolerated in the heterogenous population of patients, mostly with chronic recurrent bacterial or viral infections. "
01/01/2020 - "In children receiving only Polyoxidonium, there was a decrease in the severity of nasal breathing disorders, a decrease in the frequency of acute respiratory viral infections, an increase in the expression of antimicrobial peptide genes compared to the initial level of these indicators. "
08/01/2014 - "There were examined 198 patients, in whom immunodeficient (inflammatory, infectious and viral) diseases were revealed, as well as 10 healthy persons--for investigation of sensitivity of the blood neutrophils to immunomodulators (timalin, immunofan, polyoxidonium, timogen, erbisol). "